Oncology & Cancer

Study supports PSA screening for male BRCA2 carriers

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of the BRCA2 mutation, which is associated with a higher incidence of prostate cancer, younger age at diagnosis, and clinically ...

Oncology & Cancer

Cancer screening less likely among current smokers

(HealthDay)—Current smokers are less likely to receive guideline-concordant screening studies for breast, prostate, and colorectal cancer versus never smokers, according to a study published online May 17 in JAMA Network ...

Oncology & Cancer

Choose the right colon cancer screening option

(HealthDay)—Colon cancer is highly preventable through regular screening. But the right type of screening depends on your particular risk factors, an expert says.

Oncology & Cancer

Thirty percent fewer prostate cancer deaths with PSA screening

PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men's initially measured PSA levels proved highly significant as a ...

page 1 from 20